Status Epilepticus

• Loss of GABAergic Inhibition and GABA Receptor Desensitization: During prolonged seizure activity, continuous activation of GABA-A receptors leads to receptor internalization and desensitization, reducing the inhibitory capacity of GABAergic neurons. Benzodiazepines initially enhance GABAergic transmission, but with sustained receptor activation, the benzodiazepine-binding site becomes saturated and less responsive. Simultaneously, there is reduced expression of GABA-synthesizing enzyme glutamic acid decarboxylase (GAD) in inhibitory interneurons, further impairing the brain's capacity to terminate seizure activity. This explains why seizures become progressively resistant to treatment the longer they persist—the "time-dependent pharmacoresistance" phenomenon that makes rapid intervention critical.

• NMDA Receptor Activation and Excitotoxicity: Glutamate excitotoxicity becomes prominent as seizure duration increases. Glutamate accumulates in the synaptic cleft through reversal of reuptake transporters (GLT-1) and increased presynaptic release. This elevated glutamate continuously activates NMDA (N-methyl-D-aspartate) receptors, which are voltage-dependent and normally blocked by magnesium ions. During depolarization, the magnesium block is relieved, allowing calcium influx through NMDA channels. Excessive calcium activates multiple intracellular cascades including calpain proteases, phospholipases, and endonucleases that cause mitochondrial dysfunction, ATP depletion, cellular necrosis, and apoptotic pathways. This explains why neuronal injury in status epilepticus is directly time-dependent and why animals have demonstrable neuronal loss after 30 minutes of continuous seizures.

• Failure of Negative Feedback Mechanisms: Normal seizure termination involves rapid downregulation of excitatory inputs through multiple mechanisms: desensitization of AMPA receptors, activation of K+ channels (including ATP-sensitive and calcium-activated potassium channels), and enhancement of GABAergic signaling through GABA-B receptor activation. In status epilepticus, these homeostatic mechanisms become exhausted. GABA-B receptors paradoxically may desensitize with continuous activation. Additionally, alterations in GABA-A receptor subunit composition occur (shift from α2 to α1 subunits), which may actually enhance seizure susceptibility. The epileptic focus essentially becomes neurobiologically "locked" into a seizure state, requiring exogenous pharmacological intervention to forcefully suppress activity.

• Systemic Metabolic Derangement: Beyond the CNS, status epilepticus causes profound systemic consequences that perpetuate seizures. Intense muscle activity (in convulsive SE) generates extreme heat (hyperthermia), metabolic acidosis from anaerobic metabolism and lactic acid production, hypoxemia, hypercapnia, and electrolyte abnormalities. Hyperthermia increases neuronal metabolic rate and may lower seizure threshold. Acidosis impairs GABA-A receptor function. Hypoxemia and hypercapnia compromise cerebral autoregulation and increase intracranial pressure. These systemic derangements create a vicious cycle: seizure activity → metabolic derangement → worsening seizure threshold and reduced drug efficacy → continued seizure activity. This is why supportive care (airway management, oxygenation, temperature control) is as critical as pharmacotherapy.

• Blood-Brain Barrier Disruption and Cerebral Edema: Prolonged seizure activity causes breakdown of the blood-brain barrier (BBB) through activation of matrix metalloproteinases (MMPs, particularly MMP-9) and inflammatory cytokines (IL-1β, TNF-α). This allows extravasation of serum proteins and fluid into the parenchyma, causing vasogenic edema. Additionally, the intense metabolic activity and osmotic stress within neurons causes cytotoxic edema (cell swelling from influx of sodium and water). These forms of cerebral edema elevate intracranial pressure, which impairs cerebral perfusion and further compromises drug delivery to the epileptic focus. The development of cerebral edema is a major contributor to morbidity in prolonged SE.

• Known Epilepsy (30-40% of SE cases): Sudden or gradual cessation of antiepileptic drugs (AEDs) is the most common precipitant—whether due to patient non-compliance, drug interactions reducing AED levels, or miscalculation of doses. Patients with severe, poorly controlled epilepsy (high seizure frequency despite medication) have greater risk. Specific epilepsy syndromes carry higher SE risk: juvenile myoclonic epilepsy, myoclonic-astatic epilepsy, Dravet syndrome (genetic channelopathy), and Lennox-Gastaut syndrome. The transition from individual seizures to status epilepticus appears to depend on both the underlying seizure severity and acute precipitating factors.

• Acute CNS Infections (15-20% of SE): Meningitis (bacterial, viral, tuberculous) and encephalitis (especially herpes simplex virus, which has particular tropism for the temporal lobe) directly inflame the brain tissue and lower seizure threshold. Arboviral encephalitis (West Nile virus in North America, Japanese encephalitis in Asia) frequently presents with seizures and status epilepticus, sometimes as the initial manifestation. Brain abscess, ventriculitis, and subdural empyema similarly cause focal or generalized irritation. The prognosis of SE secondary to CNS infection depends heavily on rapid diagnosis and treatment of the underlying infection.

• Acute Cerebral Ischemia and Hemorrhage (20-30% of cases): Acute ischemic stroke, particularly large territorial infarcts affecting the cerebral cortex, frequently triggers early-onset seizures and status epilepticus, especially when the stroke involves the motor or somatosensory cortex. Intracerebral hemorrhage (hypertensive, amyloid-related, coagulopathy-induced), subarachnoid hemorrhage, and subdural hematoma (epidural hematoma rarely) can provoke SE through direct cortical irritation or increased intracranial pressure. Posterior reversible encephalopathy syndrome (PRES) associated with malignant hypertension, eclampsia, or immunosuppressive drugs frequently presents with status epilepticus and represents a particular diagnostic consideration. In acute stroke, status epilepticus occurs in approximately 2-5% of cases and carries poor prognosis, marking it as an independent negative prognostic factor.

• Metabolic and Toxic Etiologies: Hypoglycemia (especially severe cases <40 mg/dL with altered consciousness), hyponatremia (particularly acute correction causing osmotic shifts), hypocalcemia, hypomagnesemia, uremia, hepatic encephalopathy, and hyperthermia can precipitate SE. Alcohol withdrawal (a classic Board-relevant cause) presents 6-48 hours after last ethanol dose with autonomic hyperactivity, tremors, and seizures progressing to status epilepticus in 5-15% of cases. Drug toxicity (theophylline, cocaine, amphetamines, isoniazid, anticholinergics, withdrawal from benzodiazepines or barbiturates) directly lowers seizure threshold or causes metabolic derangement. Anesthetic emergence delirium with unrecognized seizures can occur with certain agents. Sepsis with or without specific metabolic abnormalities increases SE risk.

• Traumatic Brain Injury: Both acute head trauma and delayed post-traumatic seizures (developing >7 days after injury) can manifest as status epilepticus. Early post-traumatic seizures (within 7 days) occur in 5-10% of moderate-to-severe traumatic brain injury cases. Severe diffuse axonal injury, cortical contusions, and epidural/subdural hematomas particularly increase risk. Prophylactic anticonvulsants (typically phenytoin) may reduce early post-traumatic seizures but not late ones, and carry neurocognitive risks in traumatic brain injury patients.

• Neoplastic Causes: Primary brain tumors and brain metastases (especially located at gray-white matter junction and in cortical locations) can cause chronic seizures that may progress to status epilepticus. Glioblastoma multiforme and other high-grade gliomas have higher seizure propensity. Lymphoma and other infiltrative CNS neoplasms also carry risk. Seizures in a patient with known cancer frequently prompt imaging to exclude acute complications (hemorrhage, edema, new metastases).

• Genetic and Developmental Causes: Certain genetic epilepsy syndromes have particularly high SE risk: Dravet syndrome (SCN1A mutations causing severe myoclonic epilepsy of infancy with death-like episodes), progressive myoclonic epilepsies (Unverricht-Lundborg disease, Lafora disease), and other channelopathies. Cortical malformations (focal cortical dysplasia, polymicrogyria), tuberous sclerosis complex, and other neuronal migration disorders carry elevated baseline seizure burden and SE risk.

• Generalized Convulsive Status Epilepticus (GCSE) - Classic Presentation: The prototypical presentation involves sustained rhythmic tonic-clonic seizure activity without intervals of consciousness. Patients experience loss of consciousness followed by continuous tonic (sustained muscle contraction) and clonic (rhythmic jerking) activity. Intense muscular contraction generates significant heat, frequently causing hyperthermia (core temperatures >39-40°C), which exacerbates the seizure tendency. Pupils are dilated and may not respond to light. Nystagmus is common. Significant metabolic stress occurs: patients develop severe respiratory acidosis from inadequate ventilation during the tonic phase (apnea lasting several seconds during each contraction), combined with metabolic acidosis from anaerobic muscle activity and elevated lactate production. Aspiration risk is extreme given loss of protective airway reflexes; aspiration pneumonia develops in 10-20% of SE cases. Rhabdomyolysis develops from sustained muscle contraction, releasing myoglobin into the circulation—levels can exceed 100,000 units (normal <200), causing myoglobinuria and acute kidney injury. Myoglobinuria manifests as dark, cola-colored urine and appears within hours. Compartment syndrome of the legs may develop due to sustained contraction and edema. Autonomic storm occurs: tachycardia (often >120), hypertension (systolic often >180), profuse diaphoresis, and laryngeal stridor from tongue and airway edema.

• Focal Convulsive Status Epilepticus (Epilepsia Partialis Continua): Rhythmic jerking is confined to a single body region or limb, typically persisting for hours to days. Consciousness is preserved unless the focal seizure generalizes. This presentation is particularly associated with cortical lesions (stroke, tumor, focal cortical dysplasia) or specific etiologies like Rasmussen encephalitis. The focal nature can be deceptive—these seizures may be underrecognized as "status" because they lack the dramatic systemic features of GCSE, but they represent ongoing brain injury and require urgent treatment.

• Non-Convulsive Status Epilepticus (NCSE): This often-missed form accounts for 20-50% of all status epilepticus, depending on EEG screening practices. Patients may lack motor manifestations entirely, instead presenting with altered consciousness, automatisms, staring, nystagmus, or subtle rhythmic twitching of eyelids or lips. Some patients have ongoing behavioral changes or confusion without obvious seizure semiology. NCSE has multiple subtypes: (1) Absence status—continuous behavioral arrest and unresponsiveness, particularly in patients with prior childhood absence epilepsy; (2) Complex partial status—continuous automatisms, staring, and reduced awareness; (3) Simple partial NCSE—subtle cognitive or perceptual changes without altered consciousness. NCSE is frequently not recognized clinically and requires EEG to confirm diagnosis. The delayed diagnosis of NCSE means these patients often receive hours of inadequate treatment, resulting in worse outcomes than when GCSE is recognized immediately.

• Refractory Status Epilepticus (RSE) and Super-Refractory Status Epilepticus (SRSE): Defined as failure to respond to standard first-line and second-line anticonvulsants. RSE occurs in 10-40% of SE cases. These patients often have underlying structural brain lesions, severe metabolic derangement, or specific etiologies (particularly infections). SRSE, defined as SE continuing or recurring despite anesthesia for ≥24 hours, represents the most severe and challenging form with mortality rates >30%. These patients often require ICU-level care with continuous EEG monitoring and advanced imaging.

• Physical Examination Findings:
• Muscular injuries: Tongue lacerations (from biting during tonic phase), traumatic injury from falls, compartment syndrome with muscle swelling and pain with passive stretch
• Autonomic signs: Fixed and dilated pupils, profuse diaphoresis, hyperthermia (rectal temperature often most accurate), tachycardia, hypertension
• Respiratory signs: Cyanosis may develop despite oxygen supplementation due to hypoventilation during tonic phases, breath odor of acetone (from metabolic acidosis), frothy sputum (pulmonary edema in severe cases)
• Neurological exam: Loss of responsiveness, sustained muscle contractions in convulsive cases, pinpoint pupils (paradoxically, in some cases of NCSE), horizontal nystagmus, sustained deviation of eyes toward side of focal seizure (eyes look toward the lesion)
• Signs of precipitating illness: Nuchal rigidity (meningitis), petechial rash (meningococcemia), focal neurologic deficits (stroke), head trauma evidence

• Clinical Diagnosis and Recognition: Status epilepticus is primarily a clinical diagnosis requiring no tests for initial recognition—delayed diagnosis while waiting for testing is harmful. By definition, seizure activity lasting ≥5 minutes (per current ILAE definition updated in 2015) constitutes status epilepticus. The classical triad supporting immediate diagnosis includes: (1) continuous seizure activity observed by witnesses or healthcare providers, (2) loss of consciousness or altered mental status, and (3) autonomic signs (hyperthermia, tachycardia, hypertension, diaphoresis). Convulsive SE is obvious; the clinical trap involves non-convulsive status epilepticus, where the absence of motor activity may cause clinicians to attribute altered consciousness to other causes (intoxication, sepsis, hypoglycemia, stroke). Any patient with unexplained altered consciousness lasting >minutes should prompt consideration of NCSE.

• Electroencephalography (EEG): EEG is the gold standard for confirming status epilepticus and is essential for diagnosing NCSE. Continuous EEG (cEEG) monitoring should be initiated emergently in any patient with suspected SE, particularly those who are sedated or intubated. Findings include: continuous or near-continuous epileptiform discharges (spikes, spike-wave complexes, or rhythmic sharp waves) occurring at >3 Hz (high frequency distinguishes from focal seizures). In convulsive SE, EEG findings parallel seizure severity—early EEG may show discrete seizure patterns, but with prolonged duration, EEG patterns may become more subtle, mimicking interictal abnormalities (termed "burst suppression" with seizures buried within suppressed background). This EEG-clinical dissociation is critical: as SE progresses, clinical manifestations may decrease (seizure activity

Immediate stabilization (0–5 minutes, simultaneous with drug therapy)

• ABCs and monitoring: position laterally, suction, high-flow oxygen, pulse oximetry, cardiac monitor, two IVs. Intubate for failure to protect the airway or persistent hypoxemia — but paralysis masks convulsions, so pair neuromuscular blockade with continuous EEG.
• Reversible-cause screen: fingerstick glucose immediately. Give thiamine before glucose in malnourished or alcohol-using patients to avoid precipitating Wernicke encephalopathy. Correct hyponatremia, hypocalcemia, hypomagnesemia.

First-line therapy (benzodiazepines — restore GABA-A inhibition before receptor internalization makes them useless)

• IV lorazepam 4 mg IV, may repeat once, is the American Epilepsy Society (AES 2016) first choice when access exists; its low lipid solubility gives a longer CNS duration than diazepam.
• IM midazolam 10 mg IM for adults >40 kg when no IV access — equivalent or superior to IV lorazepam in the RAMPART trial. Rectal diazepam or intranasal midazolam are pediatric/prehospital alternatives.
• Underdosing benzodiazepines is the single commonest error; respiratory depression is more likely with continued seizing than with adequate dosing.

Second-line (urgent-control antiseizure medication, given whether or not seizures stopped)

• IV levetiracetam, fosphenytoin, or valproate — the ESETT trial showed roughly equal efficacy (~half of patients), so AES permits any of the three. Fosphenytoin is a water-soluble phosphate ester prodrug dosed in phenytoin equivalents (PE) and may be infused up to 150 mg PE/min; phenytoin itself must not exceed 50 mg/min. Monitor blood pressure and ECG continuously during and after either load.

Refractory SE (third line)

• Continuous anesthetic infusions: midazolam, propofol, or pentobarbital titrated to seizure suppression or burst-suppression on continuous EEG in the ICU, per Neurocritical Care Society guidance. Ketamine (NMDA blockade) is used in super-refractory cases.
• Definitive management is etiologic: acyclovir for suspected HSV encephalitis, pyridoxine for isoniazid toxicity, immunotherapy for autoimmune encephalitis, hematoma evacuation or epilepsy surgery in selected structural cases.

Avoid

• Rapid phenytoin infusion: hypotension and bradyarrhythmia from the propylene glycol/ethanol vehicle; infuse ≤50 mg/min, and never mix phenytoin in dextrose. Fosphenytoin contains no propylene glycol and may be given faster (≤150 mg PE/min) but still causes hypotension at high rates.
• Valproate in pregnancy, hepatic failure, or suspected mitochondrial/POLG disease.
• Phenytoin as monotherapy for alcohol-withdrawal or toxin-induced seizures — benzodiazepines treat the mechanism.
• Eclamptic seizures: magnesium sulfate is first-line per ACOG, not lorazepam.

Neurologic (time-dependent, the reason for the 5-minute rule)

• Excitotoxic neuronal death and hippocampal sclerosis: NMDA-mediated calcium influx kills CA1/CA3 neurons; signaled by persistent amnestic deficits and later mesial temporal atrophy with drug-resistant epilepsy.
• Cerebral edema with intracranial hypertension — emergency: BBB breakdown plus cytotoxic swelling; signaled by pupillary asymmetry, Cushing reflex, or loss of brainstem reflexes.
• Electroclinical dissociation: convulsions fade while EEG seizures continue. The clue is failure to regain consciousness within 20–30 minutes; requires continuous EEG, not reassurance.

Systemic (from sustained muscle activity and autonomic storm)

• Rhabdomyolysis → acute kidney injury — emergency: myoglobin casts obstruct tubules; signaled by cola-colored urine, urine dipstick positive for blood with few RBCs on microscopy, and markedly elevated creatine kinase. Hyperkalemia from myocyte lysis can be lethal.
• Aspiration pneumonitis/pneumonia — emergency: loss of airway reflexes; new hypoxemia and a right-lower-lobe infiltrate after the event.
• Lactic acidosis and hyperthermia: anaerobic muscle metabolism; a wide anion gap with high lactate that typically clears within an hour of seizure termination — persistent acidosis should prompt search for another cause.
• Cardiac injury: catecholamine surge causing arrhythmia, demand ischemia, takotsubo cardiomyopathy, or neurogenic pulmonary edema (frothy sputum, bilateral infiltrates with normal filling pressures).
• Musculoskeletal: tongue laceration, vertebral compression fracture, and the classic posterior shoulder dislocation.

Treatment-related

• Respiratory depression and hypotension from benzodiazepines and anesthetic infusions — anticipate intubation.
• Propofol infusion syndrome — emergency: impaired fatty-acid oxidation; signaled by refractory metabolic acidosis, rhabdomyolysis, bradyarrhythmia, and lipemic serum during prolonged high-dose infusion.
• Phenytoin: hypotension and bradyarrhythmia with rapid infusion (propylene glycol/ethanol vehicle), and purple glove syndrome — a progressive distal discoloration, edema, and pain after extravasation of the highly alkaline solution. Fosphenytoin, being water-soluble and near-physiologic in pH, still causes rate-related hypotension but rarely produces purple glove syndrome.
• Valproate: hyperammonemic encephalopathy, hepatotoxicity, pancreatitis.
• Pentobarbital: prolonged hypotension requiring vasopressors, ileus, and immunosuppression with nosocomial infection.

• Five minutes, not thirty: any convulsion lasting ≥5 minutes, or repeated seizures without recovery of consciousness between them, is status epilepticus. Do not wait for the seizure to "declare itself."
• Single best next step in a seizing patient: fingerstick glucose plus an adequately dosed IV benzodiazepine (lorazepam 4 mg IV; midazolam 10 mg IM if no IV access, per AES 2016). The classic distractor is ordering CT head or an EEG before giving the benzodiazepine — imaging follows stabilization.
• Every patient gets a second-line agent even if the benzodiazepine stops the convulsion, because the anticonvulsant effect of a benzodiazepine wears off within minutes to a few hours, so a longer-acting urgent-control agent is required to prevent recurrence. ESETT established levetiracetam, fosphenytoin, and valproate as roughly equivalent — a stem forcing you to pick "the superior agent" among these is testing that there isn't one.
• The patient who stops convulsing but does not wake up: order continuous EEG for non-convulsive status epilepticus. This is the association examiners test most often, especially in the ICU or post-cardiac-arrest patient.
• Thiamine before glucose in alcohol use disorder or malnutrition, to avoid precipitating Wernicke encephalopathy.
• Etiology-specific antidotes beat escalating antiseizure drugs: pyridoxine for isoniazid overdose, magnesium sulfate for eclampsia (ACOG), acyclovir for temporal-lobe HSV encephalitis, and benzodiazepines — not phenytoin — for alcohol-withdrawal seizures.
• Prolactin is a distractor: a transiently elevated level may follow a generalized convulsion but is neither sensitive nor specific and never guides acute management.
• Watch for the delayed complications: cola-colored urine with a dipstick positive for blood but no RBCs on microscopy is rhabdomyolysis; unexplained shoulder pain with an internally rotated arm after a convulsion is posterior shoulder dislocation.
• Refractory SE means anesthesia, not a fourth bolus: midazolam, propofol, or pentobarbital infusion in the ICU with continuous EEG titration.